Co-Dafalgan, Brausetabletten

7680473530254 CH-47353 Brausetabletten

Associated product:

CO-DAFALGAN cpr eff 500/30mg 16 pce
Co-Dafalgan, Brausetabletten
Co-Dafalgan, Brausetabletten
Co-Dafalgan, Brausetabletten
1 / 3
google

Article details

Package size
16
Selling units
16
Measure
Tablette(n)
Galenic form
Brausetabletten
Galenic group
Brausetabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/05/2025
Patient information leaflet
Français
06/05/2025
Patient information leaflet
Italien
06/05/2025
Summary of Product Characteristics
Allemand
06/05/2025
Summary of Product Characteristics
Français
06/05/2025
Summary of Product Characteristics
Italien
06/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
30.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AROMA
(N/A)
300.0 MG Substance HBESI
(N/A)
30.0 MG Substance HBESI
(N/A)
58.5 MG Substance HBESI
(N/A)
384.7 MG Substance HBESI

Reimbursement information

Public price
CHF 11.70
Specialties list
Yes
Generic
No
SL addition date: 15/03/1987

Authorization holder

UPSA Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
47353
Drug name
Co-Dafalgan, Brausetabletten
Galenic form
BRAT
ATC Code
N02AJ06
Authorization status
Z
Dispensing category
B
First authorization
03/12/1986
Authorization expiration date
31/12/9999
IT Number
01.01.2.
Domain
Human medicine
Field of application
Analgetikum

Package details

Description (FR)
CO-DAFALGAN cpr eff 500/30mg 16 pce
Description (DE)
CO-DAFALGAN Brausetabl 500/30mg 16 Stk
Market launch
03/12/1986
Narcotic (BTM)
C